Compliance With Medication Regimens for Mental and Physical Disorders
Abstract
OBJECTIVE: The authors reviewed research on medication compliance in psychiatric treatment and compared compliance rates with compliance rates in treatment of physical disorders. METHODS: MEDLINE was used to locate reports in the literature on medication compliance in psychiatric treatment for the years 1975 through 1996. These reports and studies cited in the reports were reviewed to determine the methods used to assess compliance and the compliance rates reported. Ten reports describing assessment methods and including medication compliance rates for antidepressant medication and 24 reports for antipsychotic medication were selected. They were compared with 12 reports that used microelectronic monitoring to assess medication compliance of patients with a range of nonpsychiatric disorders. RESULTS: Studies of psychiatric patients used various methods of estimating medication compliance, including interviews with patients, clinicians' judgment, and pill counts, but overall showed low rates of compliance. Patients receiving antipsychotics took an average of 58 percent of the recommended amount of the medications, with a range from 24 to 90 percent. Patients receiving antidepressants took 65 percent of the recommended amount, with a range from 40 to 90 percent. The mean compliance rate for patients with physical disorders was 76 percent, with a range from 60 to 92 percent, although the microelectronic monitoring showed frequent omission of doses and discontinuation of medication. CONCLUSIONS: Compliance with medication regimens among patients with psychiatric disorders may be lower than among patients with physical disorders. However, the difference may be largely attributable to the methods used for estimating compliance. The findings suggest the need for new and improved methods for monitoring compliance and increasing patients' compliance with pharmacotherapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Semaglutide's long-acting formulation offers advantages in severe mental illness, where medication non-adherence is a larger issue compared to other medical conditions.
“Semaglutide’s availability as a long-acting formulation offers advantages in SMI, where medication non-adherence is a larger issue compared to other medical conditions.45,46”
From Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series (2023) · cites this paper as [46]
This meta-analysis finding is consistent with a systematic review that revealed an overall medication adherence level of 58% (ranged from 24 to 90%), and medication adherence to antidepressants was 65%.
“This meta-analysis finding is consistent with a systematic review revealed an overall medication adherence level of 58% (ranged from 24 to 90%), and medication adherence to antidepressants was 65% [6].”
From Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: A systematic review and meta-analysis (2020) · cites this paper as [6]
Cites
How often is medication taken as prescribed? A novel assessment technique
Cramer, J. A. (1989) · JAMA · doi:10.1001/jama.261.22.3273 · Cited by 1,032 · see citing works
Self-citationWhy Do Schizophrenic Patients Refuse to Take Their Drugs?
Putten, T. V. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130049008 · Cited by 578 · see citing works
Herz, M. I., & Melville, C. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.801 · Cited by 456 · see citing works
Compliance Declines Between Clinic Visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390190143023 · Cited by 384 · see citing works
Self-citationCompliance with Topical Pilocarpine Treatment
Kass, M. A., Meltzer, D. W., Gordon, M. O., Cooper, D. G., & Goldberg, J. J. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90939-6 · Cited by 342 · see citing works
Trial of Maintenance Therapy in Schizophrenia
Leff, J., & Wing, J. K. (1971) · BMJ · doi:10.1136/bmj.3.5775.599 · Cited by 339 · see citing works
Waterhouse, D. M., Calzone, K. A., Mele, C., & Brenner, D. E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1189 · Cited by 313 · see citing works
A two-year prospective study of treatment compliance in patients with schizophrenia
Buchanan, A. W. (1992) · Psychological Medicine · doi:10.1017/s0033291700038228 · Cited by 287 · see citing works
Drug and Sociotherapy in the Aftercare of Schizophrenic Patients
Hogarty, G. E. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310038007 · Cited by 283 · see citing works
Compliance with antipsychotic drug treatment: influence of side effects
Ww, F., Meise, U., Günther, V., & Kurz, M. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05859.x · Cited by 241 · see citing works
Do psyhiatric out-patients take their drugs?
Willcox, D. R. C., Gillan, R., & Hare, E. H. (1965) · BMJ · doi:10.1136/bmj.2.5465.790 · Cited by 222 · see citing works
Why Patients Leave Psychotherapy
Frank, J. D. (1957) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1957.02330330069013 · Cited by 199 · see citing works
Falloon, I. R. H., Watt, D. C., & Shepherd, M. A. (1978) · Psychological Medicine · doi:10.1017/s0033291700006632 · Cited by 196 · see citing works
Microelectronic Systems for Monitoring and Enhancing Patient Compliance With Medication Regimens
Cramer, J. A. (1995) · Drugs · doi:10.2165/00003495-199549030-00001 · Cited by 174 · see citing works
Self-citationPullar, T., Birtwell, A. J., Wiles, P. G., Hay, A., & Feely, M. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.191 · Cited by 168 · see citing works
Sullivan, G., Wells, K. B., Morgenstern, H., & LEAKE, B. D. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1749 · Cited by 160 · see citing works
The compliance with antidepressants in general practice
Maddox, J. C., Levi, M., & Thompson, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800108 · Cited by 148 · see citing works
Improving Inhaler Adherence in a Clinical Trial Through the Use of the Nebulizer Chronolog
Nides, M. A., Tashkin, D. P., Simmons, M. S., Wise, R. A., Li, V. C., & Rand, C. S. (1993) · CHEST Journal · doi:10.1378/chest.104.2.501 · Cited by 146 · see citing works
A FOLLOW‐UP OF SCHIZOPHRENIC PATIENTS IN EDINBURGH
Renton, C. A., Affleck, J. W., CARSTAIRS, G. M., & Forrest, A. D. (1963) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1963.tb07482.x · Cited by 145 · see citing works
Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants
Montgomery, S. A., & Kasper, S. F. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199501004-00005 · Cited by 144 · see citing works
Medication Compliance and Health Education Among Outpatients With Chronic Mental Disorders
Kelly, G. R., & Scott, J. E. (1990) · Medical Care · doi:10.1097/00005650-199012000-00006 · Cited by 139 · see citing works
The General Practitioner and the Schizophrenic Patient
Parkes, C. M., Brown, G. W., & Monck, E. (1962) · BMJ · doi:10.1136/bmj.1.5283.972 · Cited by 136 · see citing works
Dynamics of drug regimen compliance ? its assessment by microprocessor-based monitoring
Kruse, W., & Weber, E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278582 · Cited by 131 · see citing works
Compliance with treatment in schizophrenia: a drug intervention program in a developing country
Salleh, M. R., & Yahya, H. M. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09790.x · Cited by 125 · see citing works
Information, compliance and side‐effects: a study of patients on antidepressant medication.
Myers, E. D., & Calvert, E. J. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb04993.x · Cited by 114 · see citing works
Predicting Medication Compliance in a Psychotic Population
Adams, S. G., & HOWE, J. T. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199309000-00005 · Cited by 108 · see citing works
Pill Count Measures of Compliance in a Drug Trial: Variability and Suitability
Rudd, P., Byyny, R. L., Zachary, V., Loverde, M., Mitchell, W. D., Titus, C., & Marshall, G. D. (1988) · American Journal of Hypertension · doi:10.1093/ajh/1.3.309 · Cited by 106 · see citing works
Mengden, T., Binswanger, B., Spühler, T., Weisser, B., & Vetter, W. (1993) · Journal of Hypertension · doi:10.1097/00004872-199312000-00013 · Cited by 95 · see citing works
Out-patient Compliance with Antidepressant Medication
Myers, E. D., & Branthwaite, A. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.160.1.83 · Cited by 94 · see citing works
Compliance assessed by the Medication Event Monitoring System.
Olivieri, N. F., Matsui, D. M., Hermann, C., & Koren, G. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.12.1399 · Cited by 87 · see citing works
Kruse, W., Eggert-Kruse, W., Rampmaier, J., Runnebaum, B., & Weber, E. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314990 · Cited by 86 · see citing works
Compliance declines between clinic visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.7.1509 · Cited by 83 · see citing works
Self-citationAdherence to Treatment Regimen in a Lithium Carbonate Clinic
Connelly, C. E. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290050057011 · Cited by 81 · see citing works
Relationship between medication compliance and medical outcomes
Cramer, J. A. (1995) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/52.14_suppl_3.s27 · Cited by 67 · see citing works
Self-citationPhenothiazine Intake and Staff Attitudes
Irwin, D. S., Weitzel, W. D., & Morgan, D. W. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1631 · Cited by 61 · see citing works
Attitudes and Behaviors of Acute and Chronic Schizophrenic Patients Regarding Ambultory Treatment
Serban, G., & Thomas, A. J. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.9.991 · Cited by 60 · see citing works
From compliance to alliance A quarter century of research
Blackwell, B. (1996) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(96)80017-9 · Cited by 59 · see citing works
Long-Acting Oral vs Injectable Antipsychotic Drugs in Schizophrenics
Quitkin, F. M. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310095007 · Cited by 55 · see citing works
Neurotics Who Fail to Take their Drugs
Lipman, R. S., Rickels, K., UHLENHUTH, E. H., Park, L. C., & Fisher, S. (1965) · The British Journal of Psychiatry · doi:10.1192/bjp.111.480.1043 · Cited by 52 · see citing works
Use of Antipsychotic and Antidepressant Drugs by Chronically Ill Patients
McClellan, T. A., & Cowan, G. O. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.12.1771 · Cited by 38 · see citing works
SIDE-EFFECTS, RESISTANCE AND DOSAGE DEVIATIONS IN PSYCHIATRIC OUTPATIENTS TREATED WITH TRANQUILIZERS
MICHAIIX, W. W. (1961) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196109000-00003 · Cited by 34 · see citing works
Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring
Kruse, W., Nikolaus, T., Rampmaier, J., Weber, E., & Schlierf, G. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315385 · Cited by 31 · see citing works
A comparison of acceptors and resistors of drug treatment as an adjunct to psychotherapy.
Raskin, A. (1961) · Journal of Consulting Psychology · doi:10.1037/h0046007 · Cited by 27 · see citing works
Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics
Kapur, S., Ganguli, R., Ulrich, R. F., & Raghu, U. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90020-r · Cited by 26 · see citing works
Straka, R. J., Fish, J. T., Benson, S. R., & Suh, J. T. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04222.x · Cited by 20 · see citing works
THE EFFECT OF CHLORPROMAZINE IN REDUCING THE RELAPSE RATE IN 716 RELEASED PATIENTS: STUDY 3
POLLACK, B. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.114.8.749 · Cited by 18 · see citing works
Drug-Related Admissions to a Veterans' Administration Psychiatric Unit
Salem, R. B., Keane, T. M., & Williams, J. G. (1984) · Annals of Pharmacotherapy · doi:10.1177/106002808401800117 · Cited by 14 · see citing works
A PRELIMINARY REPORT ON THE CONTINUED POST-HOSPITAL USE OF TRANQUILIZING DRUGS
Wolff, R. J., & COLACINO, D. M. (1961) · American Journal of Psychiatry · doi:10.1176/ajp.118.6.499 · Cited by 14 · see citing works
Variable patient compliance in ambulatory trials—nuisance, threat, opportunity
Urquhart, J. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.4.643 · Cited by 13 · see citing works
The Prevalence and Nature of Lithium Noncompliance among Chinese Psychiatric Patients in Hong Kong
Lee, S. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199310000-00008 · Cited by 10 · see citing works
Editorial: Single daily dose of antidepressants
Ayd, F. J. (1974) · JAMA · doi:10.1001/jama.230.2.263 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974 · see citing works
How stigma interferes with mental health care.
Corrigan, P. (2004) · American Psychologist · doi:10.1037/0003-066x.59.7.614 · Cited by 3,648 · see citing works
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024 · see citing works
Mental illness stigma: Concepts, consequences, and initiatives to reduce stigma
Rüsch, N., Angermeyer, M. C., & Corrigan, P. W. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.04.004 · Cited by 1,658 · see citing works
Bruce, M. L., Ten Have, T. R., Reynolds III, C. F., Katz, I. I., Schulberg, H. C., Mulsant, B. H., Brown, G. K., McAvay, G. J., Pearson, J. L., & Alexopoulos, G. S. (2004) · JAMA · doi:10.1001/jama.291.9.1081 · Cited by 963 · see citing works
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 901 · see citing works
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · see citing works
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633 · see citing works
Patient adherence to medical treatment: a review of reviews
van Dulmen, S., Sluijs, E., van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-55 · Cited by 627 · see citing works
Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., & Korhonen, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081224 · Cited by 619 · see citing works
Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 607 · see citing works
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Haddad, P. M., Brain, C., & Scott, J. L. (2014) · Patient Related Outcome Measures · doi:10.2147/prom.s42735 · Cited by 587 · see citing works
Adequacy of Treatment for Serious Mental Illness in the United States
Wang, P. S., Demler, O., & Kessler, R. C. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.1.92 · Cited by 581 · see citing works
Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2020) · Systematic Reviews · doi:10.1186/s13643-020-1274-3 · Cited by 555 · see citing works
Kane, J. M., Kishimoto, T., & Correll, C. U. (2013) · World Psychiatry · doi:10.1002/wps.20060 · Cited by 520 · see citing works
Antipsychotic medication in schizophrenia: a review
Lally, J., & MacCabe, J. H. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv017 · Cited by 515 · see citing works
Kane, J. M., Eerdekens, M., Lindenmayer, J., Keith, S. J., Lesem, M. D., & Karcher, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1125 · Cited by 489 · see citing works
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450 · see citing works
Leucht, C., Heres, S., Kane, J. M., Kissling, W., Davis, J. M., & Leucht, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.020 · Cited by 419 · see citing works
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J. A., Glenthoj, B. Y., Gattaz, W. F., Thibaut, F., Möller, H., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 418 · see citing works
Cramer, J. A., Amonkar, M. M., Hebborn, A., & Altman, R. D. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x61875 · Cited by 390 · see citing works
Self-citationAdherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients
García, S., Martínez‐Cengotitabengoa, M., López-Zurbano, S., Zorrilla, E. P., López‐Mahía, P., Vieta, E., & González-Pinto, A. M. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000523 · Cited by 363 · see citing works
Barnes, T. R. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 357 · see citing works
How often do patients with psychosis fail to adhere to treatment programmes? A systematic review
Nosè, M., Barbui, C., & Tansella, M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008328 · Cited by 353 · see citing works
Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission
Valenstein, M. M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R., & Stavenger, T. (2002) · Medical Care · doi:10.1097/00005650-200208000-00002 · Cited by 339 · see citing works
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N. G., & Sawa, A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 313 · see citing works
Hallucinations: The science of idiosyncratic perception.
Aleman, A., & Larøi, F. (2008) · American Psychological Association eBooks · doi:10.1037/11751-000 · Cited by 283 · see citing works
Svarstad, B. L., Shireman, T. I., & Sweeney, J. K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.6.805 · Cited by 281 · see citing works
Poor Antipsychotic Adherence Among Patients With Schizophrenia: Medication and Patient Factors
Valenstein, M. M., Blow, F. C., Copeland, L. A., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R., & Stavenger, T. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007076 · Cited by 273 · see citing works
What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders
Chakrabarti, S. (2014) · World Journal of Psychiatry · doi:10.5498/wjp.v4.i2.30 · Cited by 257 · see citing works
Adherence to Medication in Patients with Dementia
Arlt, S., Lindner, R., Rösler, A., & Renteln-Kruse, W. V. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00005 · Cited by 249 · see citing works
Schaub, A.-C., Schneider, E., Vázquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., Doll, J. P. K., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01977-z · Cited by 273 · see citing works
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226 · see citing works
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
Leucht, S., & Heres, S. (2006) · PubMed · Cited by 226 · see citing works
Lecomte, T., Spidel, A. L., LECLERC, C., MacEwan, G. W., GREAVES, C., & Bentall, R. P. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.024 · Cited by 212 · see citing works
Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044987 · Cited by 210 · see citing works
Sikirica, V., Lü, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 206 · see citing works
Use of ecological momentary assessment in mood disorders research
Wenze, S. J., & Miller, I. W. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.06.007 · Cited by 205 · see citing works
Remission in Depressed Geriatric Primary Care Patients: A Report From the PROSPECT Study
Alexopoulos, G. S., Katz, I. R., BRUCE, M. L., Heo, M., Have, T. T., Raue, P. J., Bogner, H. R., Schulberg, H. C., Mulsant, B. H., Reynolds, C. F., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.718 · Cited by 205 · see citing works
Sun, S. X., Liu, G. G., Christensen, D. B., & Fu, A. Z. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226050 · Cited by 196 · see citing works
Co-occurrence of HIV and Serious Mental Illness Among Medicaid Recipients
Blank, M. B., Mandell, D. S., Aiken, L. H., & Hadley, T. R. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.868 · Cited by 195 · see citing works
Engagement and retention in digital mental health interventions: a narrative review
Boucher, E. M., & Raiker, J. S. (2024) · BMC Digital Health · doi:10.1186/s44247-024-00105-9 · Cited by 201 · see citing works
Why don't patients take their medicine? Reasons and solutions in psychiatry
Mitchell, A. J., & Selmes, T. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.106.003194 · Cited by 190 · see citing works
Conley, R. R., Gupta, S., & Sathyan, G. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132613 · Cited by 188 · see citing works
Clinical interventions for treatment non-adherence in psychosis: Meta-analysis
Nosè, M., Barbui, C., Gray, R. J., & Tansella, M. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.3.197 · Cited by 185 · see citing works
Identifying and improving non‐adherence in bipolar disorders
Colom, F., Vieta, E., Tacchi, M., Sánchez‐Moreno, J., & Scott, J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00248.x · Cited by 182 · see citing works
Barkhof, E., Meijer, C. J., de Sonneville, L. M. J., Linszen, D. H., & de Haan, L. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.005 · Cited by 183 · see citing works
The Role of Adherence on the Effectiveness of Nonpharmacologic Interventions
Inouye, S. K., Bogardus, S. T., Williams, C. S., Leo-Summers, L. S., & Agostini, J. V. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.958 · Cited by 179 · see citing works
Pharmacogenetics of antidepressant response
Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100059 · Cited by 179 · see citing works
Treatment Adherence With Lithium and Anticonvulsant Medications Among Patients With Bipolar Disorder
Sajatovic, M., Valenstein, M., Blow, F., Ganoczy, D., & Ignacio, R. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.855 · Cited by 172 · see citing works
An Economic Review of Compliance With Medication Therapy in the Treatment of Schizophrenia
Thieda, P., Beard, S. M., Richter, A., & Kane, J. M. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.4.508 · Cited by 169 · see citing works
Swift, J. K., Greenberg, R. P., Tompkins, K. A., & Parkin, S. R. (2017) · Psychotherapy · doi:10.1037/pst0000104 · Cited by 167 · see citing works
Dropout rates in randomised antipsychotic drug trials
Wahlbeck, K., Tuunainen, A., Ahokas, A., & Leucht, S. (2001) · Psychopharmacology · doi:10.1007/s002130100711 · Cited by 167 · see citing works
Gray, R. J., Wykes, T., & Gournay, K. (2002) · Journal of Psychiatric and Mental Health Nursing · doi:10.1046/j.1365-2850.2002.00474.x · Cited by 166 · see citing works
Partial compliance in schizophrenia and the impact on patient outcomes
Llorca, P. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.012 · Cited by 163 · see citing works
Enhancement of Treatment Adherence Among Patients With Bipolar Disorder
Sajatovic, M., Davies, M. A., & Hrouda, D. R. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.3.264 · Cited by 162 · see citing works
Lee, S., Chiu, M. Y.-L., Tsang, A., Chui, H. C., & Kleinman, A. (2005) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.08.016 · Cited by 151 · see citing works
Liu‐Seifert, H., Adams, D. H., & Kinon, B. J. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-21 · Cited by 153 · see citing works
Self-Control: Theory and Research
Strayhorn, J. M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200201000-00006 · Cited by 153 · see citing works
Dropout Rates in Placebo-Controlled and Active-Control Clinical Trials of Antipsychotic Drugs
Kemmler, G., Hummer, M., Widschwendter, C. G., & Fleischhacker, W. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1305 · Cited by 146 · see citing works
Medication nonadherence and psychiatry
Chapman, S. C. E., & Horne, R. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283642da4 · Cited by 142 · see citing works
Montes, J. M. G., Medina, E., Gómez-Beneyto, M., & Mauriño, J. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.034 · Cited by 140 · see citing works
Integration of Depression and Hypertension Treatment: A Pilot, Randomized Controlled Trial
Bogner, H. R., & de Vries, H. F. (2008) · The Annals of Family Medicine · doi:10.1370/afm.843 · Cited by 140 · see citing works
Treatment-adherence in bipolar disorder: A patient-centred approach
Chakrabarti, S. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i4.399 · Cited by 145 · see citing works
Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder
GOFF, D. C., Hill, M. B., & Freudenreich, O. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9096su1cc.04 · Cited by 136 · see citing works
Risk Factors Promoting Hypertensive Crises: Evidence From a Longitudinal Study
Saguner, A. M., Dür, S., Perrig, M., Schiemann, U., Stuck, A. E., Bürgi, U., Erné, P., & Schoenenberger, A. W. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.71 · Cited by 134 · see citing works
Non-adherence with psychotropic medications in the general population
Bulloch, A. G. M., & Patten, S. B. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0041-5 · Cited by 129 · see citing works
Mental Illness Stereotypes and Clinical Care: Do People Avoid Treatment Because of Stigma?
Corrigan, P. W., & Rüsch, N. (2002) · Psychiatric Rehabilitation Skills · doi:10.1080/10973430208408441 · Cited by 129 · see citing works
Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey
Ashton, A. K., Jamerson, B. D., Weinstein, W., & Wagoner, C. (2005) · Current Therapeutic Research · doi:10.1016/j.curtheres.2005.04.006 · Cited by 129 · see citing works
Enhancing Medication Compliance for People with Serious Mental Illness
Cramer, J. A., & Rosenheck, R. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199901000-00009 · Cited by 128 · see citing works
Self-citationClinical Factors Associated With Employment Among People With Severe Mental Illness
Razzano, L. A., Cook, J. Α., Burke-Miller, J. K., Mueser, K. T., Pickett‐Schenk, S. A., Grey, D. D., Goldberg, R. W., Blyler, C. R., Gold, P. B., Leff, H. S., et al. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000185939.11282.3e · Cited by 126 · see citing works
Diaz, E., Levine, H. B., Sullivan, M. C., Sernyak, M. J., Hawkins, K. A., Cramer, J. A., & Woods, S. W. (2001) · PubMed Central · Cited by 123 · see citing works
Self-citationImpact of Antidepressant Drug Adherence on Comorbid Medication Use and Resource Utilization
Katon, W. J., Cantrell, C. R., Sokol, M. C., Chiao, E., & Gdovin, J. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2497 · Cited by 121 · see citing works
Hack, S., & Chow, B. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143465 · Cited by 120 · see citing works
Remington, G., Kwon, J. S., COLLINS, A., Laporte, D., MANN, S., & Christensen, B. K. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.015 · Cited by 118 · see citing works
Harrow, M., Jobe, T. H., & Faull, R. N. (2014) · Psychological Medicine · doi:10.1017/s0033291714000610 · Cited by 116 · see citing works
Psychiatric Predictors of Noncompliance in Inflammatory Bowel Disease
Nigro, G., Angelini, G., Grosso, S. B., Caula, G., & Sategna-Guidetti, C. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200101000-00015 · Cited by 114 · see citing works
Shi, L., Ascher‐Svanum, H., Zhu, B., Faries, D. E., Montgomery, W. S., & Marder, S. R. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.4.482 · Cited by 112 · see citing works
Antiepileptic drugs in epilepsy and other disorders—A population-based study of prescriptions
Landmark, C. J., Larsson, P. G., Rytter, E., & Johannessen, S. I. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.07.005 · Cited by 111 · see citing works
Ascher‐Svanum, H., Zhu, B., Faries, D. E., Landbloom, R. P., Swartz, M. S., & Swanson, J. W. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-8 · Cited by 110 · see citing works
Villeneuve, K., Potvin, S., LESAGE, A. D., & Nicole, L. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.003 · Cited by 110 · see citing works
Extrapyramidal side effects are unacceptable
Kane, J. M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00109-2 · Cited by 110 · see citing works
Why aren't depot antipsychotics prescribed more often and what can be done about it?
Patel, M. X., & David, A. S. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.3.203 · Cited by 109 · see citing works
College Students' Attitudes Toward Mental Illness: An Examination of the Stigma Process1
Phelan, J. E., & Basow, S. A. (2007) · Journal of Applied Social Psychology · doi:10.1111/j.1559-1816.2007.00286.x · Cited by 108 · see citing works
Risk factors and predictors of compliance in depression
Demyttenaere, K. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00095-6 · Cited by 107 · see citing works
Therapeutic drug monitoring of psychotropic medications
Mitchell, P. B. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00174.x · Cited by 107 · see citing works
Adherence to pharmacotherapy in patients with alcohol and opioid dependence
Weiss, R. D. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00884.x · Cited by 107 · see citing works
Medication Adherence Among Psychotic Patients Before Admission to Inpatient Treatment
Rittmannsberger, H., Pachinger, T., Keppelmüller, P., & Wancata, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.2.174 · Cited by 106 · see citing works
A Duty to Deceive: Placebos in Clinical Practice
Foddy, B. (2009) · The American Journal of Bioethics · doi:10.1080/15265160903318350 · Cited by 105 · see citing works
Glenn, T., & Monteith, S. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0523-3 · Cited by 104 · see citing works
Patient Compliance with Drug Therapy in Schizophrenia
Lindström, E., & Bingefors, K. (2000) · PharmacoEconomics · doi:10.2165/00019053-200018020-00002 · Cited by 102 · see citing works
Adherence to Medication Regimens and Participation in Dual-Focus Self-Help Groups
Magura, S., Laudet, A. B., Mahmood, D., Rosenblum, A., & Knight, E. L. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.3.310 · Cited by 100 · see citing works
Schneider, E., Doll, J. P. K., Schweinfurth, N., Kettelhack, C., Schaub, A.-C., Yamanbaeva, G., Varghese, N., Mählmann, L., Brand, S., Eckert, A., et al. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.220117 · Cited by 107 · see citing works
Fleck, M. P. D. A., Berlim, M. T., Lafer, B., Sougey, É. B., Porto, J. A. D., Brasil, M. A. A., Juruena, M. F., & Hetem, L. A. (2009) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462009000500003 · Cited by 101 · see citing works
Medication Adherence in Chronic Disease: Issues in Posttransplant Immunosuppression
Hansen, R. A., Seifeldin, R., & Noe, L. L. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.02.074 · Cited by 98 · see citing works
Haddad, P. M., Taylor, M., & Niaz, O. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s20 · Cited by 97 · see citing works
Loots, E., Goossens, E., Vanwesemael, T., Morrens, M., Rompaey, B. V., & Dilles, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910213 · Cited by 112 · see citing works
Diretrizes da Associação Médica Brasileira para o tratamento da depressão (versão integral)
Fleck, M. P. D. A., Lafer, B., Sougey, É. B., Porto, J. A. D., Brasil, M. A. A., & Juruena, M. F. (2003) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462003000200013 · Cited by 97 · see citing works
Treatment Adherence and Long-Term Outcomes
Kane, J. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900026304 · Cited by 97 · see citing works
Integrating Type 2 Diabetes Mellitus and Depression Treatment Among African Americans
Bogner, H. R., & de Vries, H. F. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709356115 · Cited by 96 · see citing works
- Authors
- Cramer, J. A., & Rosenheck, R.
- Affiliations
- Yale University (US)
- ORCID
- Rosenheck, Robert
- Venue
- Psychiatric Services
- Published
- 1998-02
- Volume
- 49
- Issue
- 2
- Pages
- 196-201
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2162391751
- Cited by
- 725
- References
- 50
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 16 · 2023: 35 · 2022: 28 · 2021: 15 · 2020: 26 · 2019: 18 · 2018: 20 · 2017: 21 · 2016: 28 · 2015: 29 · 2014: 32 · 2013: 40 · 2012: 39
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institutes of Health (5r24mh054446-05)
- National Institute of Mental Health (R24-MH-54446)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Keywords
- medication adherence, mental illness, physical disorders, antipsychotic drugs, antidepressants, pill count, dose omission, pharmacotherapy
- MeSH terms
- Antidepressive Agents, Mental Disorders, Health Status, Humans, Patient Compliance, Time Factors, Antipsychotic Agents, Drug Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
